265) found that children of depressed mothers, compared to children of non-depressed moth |
266) T use appears to be more common in adults compared to children. |
267) t-TBI, only 35 % of PARV-ir (p < 0.001 compared to controls), 63 % of CCK-ir (p & |
268) of PARV-immunoreactive (ir) (p < 0.001 compared to controls), 77 % of CR-ir (p &l |
269) models using various cost functions were compared to experimental data from 15 heal |
270) The model shows excellent agreement compared to experimental data obtained fro |
271) ume were significantly reduced in group 3 compared to groups 1 and 2. |
272) f nuclear factor κΒ ligand (RANKL) when compared to groups II, III and IV (p < |
273) h but had similar transfection efficiency compared to its parent plasmid (pEGFP-N2). |
274) achieves stronger platelet inhibition as compared to its predecessor clopidogrel. |
275) gs with primary appendicular bone tumours compared to long bone survey radiography, |
276) onfer improved mid- and long-term patency compared to long saphenous veins. |
277) can origin reported higher odds of asthma compared to non-Hispanic white children. |
278) ht gain (GWG) in Hispanic and Black women compared to non-Hispanic women in Colorado |
279) duced number of CD34+/α6 integrin+ cells compared to non-transgenic (NTg) littermat |
280) (S.Mol) of the hippocampus at 12 months compared to non-transgenic (non-Tg) animal |
281) y of life is lower for people with autism compared to people without autism, and tha |
282) m experience a much lower quality of life compared to people without autism. |
283) ther enhancement in drug dissolution when compared to plain drug and marketed tablet |
284) eability coefficient (Papp) from S-SNEDDS compared to plain drug. |
285) Compared to previous research on adults wi |
286) ically changing sets of problem instances compared to previous approaches. |
287) ker) aggravated stress ulcer formation as compared to vehicle treated CRS exposed ra |
288) x and GSH and elevations in brain MDA, as compared to vehicle treated CRS rats. |
289) er numbers of previous sexual assaults as compared to youth who offended against non |
290) ave higher risk and criminogenic needs as compared to youth who only sexually offend |
291) ic genetic diversity of 0-0.97% for nad1, compared to 0-0.42% for ITS-2. |
292) ients, 29 % (n = 5) of asthma patients compared to 0.05 % (n = 1) of the contr |
293) ucing memory impairment in rats (2 mg/kg) compared to 0.5 or 1 mg/kg dose. |
294) ated in 11.6% of the homeless population, compared to 0.7% in the BGPS. |
295) orted experiencing gender discrimination, compared to 0.9% among men. |
296) as 21.1 and 28.4% in the US respectively, compared to 11.5 and 12.9% in MX (p < 0 |
297) side effects and treatment outcomes were compared to 14 contemporary control patien |
|